← Human Trials & Peer-Reviewed Studies

Relationships Between the Nicotine Metabolite Ratio and Laboratory Assessments of Smoking Reinforcement and Craving Among Adults in a Smoking Cessation Trial.

Plain-language guide to PMID 37996099 (2024): randomized controlled trial of Therapeutic nicotine (patch, non-peptide) in 252 adults.

Key Facts

PMID
37996099
Journal
Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco
Year
2024
Study type
Randomized Controlled Trial
Authors
Cooper RK et al. (6 authors)
DOI
10.1093/ntr/ntad232

What This Study Did, in Plain Language

What Was Tested

This randomized controlled trial looks at Therapeutic nicotine (patch, non-peptide).

People who metabolize nicotine more quickly are generally less successful at quitting smoking.

However, the mechanisms that link individual differences in the nicotine metabolite ratio (NMR), a phenotypic biomarker of the rate of nicotine clearance, to smoking outcomes are unclear.

Who Took Part

According to the abstract, 252 adults were involved.

By PubMed's age tags, the people studied were young adults, adults and middle-aged adults, both men and women.

Participants were 252 adults who smoke cigarettes enrolled in a randomized controlled smoking cessation trial (NCT03262662) conducted in Buffalo, New York, USA.

Participants completed the Choice Behavior Under Cued Conditions (CBUCC) paradigm, a laboratory choice procedure, ~1 week before the first cessation treatment visit, at which time a saliva sample was collected for NMR assessment.

How the Study Was Run

The researchers set it up as a randomized study.

Because people in this Therapeutic nicotine (patch, non-peptide) study were split into groups at random, differences between the groups are less likely to reflect who happened to join each one.

What Was Measured

However, the mechanisms that link individual differences in the nicotine metabolite ratio (NMR), a phenotypic biomarker of the rate of nicotine clearance, to smoking outcomes are unclear.

The subject headings attached to it are Craving, Smoking Cessation, Reinforcement, Psychology, Nicotine, Cues, Saliva and Cigarette Smoking.

What This Means in Plain Language

The paper is a randomized study of Therapeutic nicotine (patch, non-peptide) in 252 adults.

The abstract goes on to report its results in about 6 sentences; this page does not restate them, so read the paper for the findings and their limits.

The publication is from 2024 (Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco), a journal based in England.

More context: the Therapeutic nicotine (patch, non-peptide) compound page, all human trials.

Our Notes on the Compound

Therapeutic nicotine (patch, non-peptide): Pure nicotine as a signaling tool, separated from smoking and vaping.

Related Pages

Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.